Table 1.
Short-term analysis |
Long-term analysis |
|||
---|---|---|---|---|
HIV infected | HIV uninfected | HIV infected | HIV uninfected | |
Characteristic | n = 158a | n = 650b (%) | n = 151a (%) | n = 650b (%) |
Country/referral population | ||||
Uganda | ||||
Family planning and MCH clinic | 36 (23) | 291 (45) | 38 (25) | 299 (46) |
STD clinics, sex worker networks, military wives | 18 (11) | 59 (9) | 16 (11) | 62 (10) |
Zimbabwe | 104 (66) | 300 (46) | 97 (64) | 289 (45) |
Employed | ||||
Yes | 80 (51) | 325 (50) | 75 (50) | 326 (50) |
No | 78 (49) | 325 (50) | 76 (50) | 324 (50) |
Cohabit with primary partner | ||||
Yes | 122 (77) | 534 (82) | 115 (76) | 538 (83) |
No | 36 (23) | 116 (18) | 36 (24) | 112 (17) |
Alcohol or drug use during sex in last 3 months | ||||
Yes | 6 (4) | 15 (2) | 6 (4) | 19 (3) |
No | 152 (96) | 635 (98) | 145 (96) | 631 (97) |
Current contraceptive method | ||||
COC | 43 (27) | 234 (36) | 45 (30) | 218 (34) |
DMPA | 65 (41) | 239 (37) | 64 (42) | 258 (40) |
COC and DMPA | 1 (1) | 2 (0.3) | 0 (0) | 3 (1) |
Non-hormonal method | 49 (31) | 175 (27) | 42 (28) | 171 (26) |
Commercial sex in last 3 months | ||||
Yes | 2 (1) | 5 (1) | 2 (1) | 5 (1) |
No | 156 (99) | 645 (99) | 149 (99) | 645 (99) |
Number of sex partners in last 3 months | ||||
0 partners | 6 (4) | 12 (2) | 7 (5) | 4 (1) |
1 partner | 142 (90) | 629 (97) | 134 (89) | 628 (97) |
≥2 partners | 10 (6) | 9 (1) | 10 (7) | 18 (3) |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
Age (years) | 24.9 (4.1) | 25.6 (4.4) | 25.0 (4.2) | 25.5 (4.5) |
Age at coital debut (years) | 17.6 (2.2) | 17.5 (2.5) | 17.5 (2.2) | 17.5 (2.7) |
Education (years) | 9.2 (2.5) | 9.2 (3.0) | 9.1 (2.5) | 9.1 (3.1) |
Partner nights away in last 30 days | 8.3 (11.1) | 6.8 (10.7) | 8.0 (10.9) | 6.7 (10.7) |
a137 HIV-infected women are common to the short- and long-term analyses.
b225 HIV-uninfected women are common to both the short- and long-term analyses.
MCH = maternal-child health; STD = sexually transmitted disease; COC = combined oral contraceptive pills; DMPA = depot medroxyprogesterone acetate.